SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-013403
Filing Date
2018-05-14
Accepted
2018-05-14 16:02:23
Documents
59
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fixx-10q_20180331.htm 10-Q 1717168
2 EX-31.1 fixx-ex311_9.htm EX-31.1 16535
3 EX-31.2 fixx-ex312_8.htm EX-31.2 18421
4 EX-32.1 fixx-ex321_7.htm EX-32.1 9703
5 EX-32.2 fixx-ex322_6.htm EX-32.2 9921
  Complete submission text file 0001564590-18-013403.txt   5690769

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fixx-20180331.xml EX-101.INS 1169215
7 XBRL TAXONOMY EXTENSION SCHEMA fixx-20180331.xsd EX-101.SCH 45789
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fixx-20180331_cal.xml EX-101.CAL 41248
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fixx-20180331_def.xml EX-101.DEF 131356
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fixx-20180331_lab.xml EX-101.LAB 324479
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fixx-20180331_pre.xml EX-101.PRE 241169
Mailing Address 45 WIGGINS AVE. BEDFORD MA 01730
Business Address 45 WIGGINS AVE. BEDFORD MA 01730 857-305-1825
Homology Medicines, Inc. (Filer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38433 | Film No.: 18830526
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences